Join a Clinical Trial
Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.
Clinical Trial Details
A Safety and Efficacy Study of CC-90009 Combinations in Subjects With Acute Myeloid Leukemia
Complete Title: An Exploratory Phase 1b Open-label Multi-arm Trial to Evaluate the Safety and Efficacy of
CC-90009 in Combination with Anti-Leukemia Agents in Subjects with Acute Myeloid
Leukemia
Trial Phase: I/II
Investigator: Mary-Elizabeth Percival
CC-90009-AML-002 is an exploratory Phase 1b open-label multi-arm trial to evaluate the safety and efficacy of CC-90009 in combination with anti-leukemia agents in subjects with acute myeloid leukemia (AML).
Keywords:
- Leukemia, Acute Myeloid (AML)
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Contact Us
If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.
Adult
I/II
Mary-Elizabeth Percival
RG1007204
NCT04336982
An Exploratory Phase 1b Open-label Multi-arm Trial to Evaluate the Safety and Efficacy of
CC-90009 in Combination with Anti-Leukemia Agents in Subjects with Acute Myeloid
Leukemia
Leukemia, Acute Myeloid (AML)